$ACAD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACADIA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACADIA PHARMACEUTICALS INC. Get notifications about new insider transactions in ACADIA PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 24 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | M | 19.65 | 7,074 | 139,004 | 8,551 | |
Apr 24 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Sell | S | 50.07 | 18,949 | 948,729 | 6,027 | 25 K to 6 K (-75.87 %) |
Apr 24 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Buy | M | 21.28 | 11,875 | 252,700 | 24,976 | 13.1 K to 25 K (+90.64 %) |
Apr 24 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Buy | M | 19.65 | 7,074 | 139,004 | 13,101 | 6 K to 13.1 K (+117.37 %) |
Apr 22 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | M | 19.98 | 19,644 | 392,487 | 51,606 | |
Apr 22 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | M | 19.65 | 34,375 | 675,469 | 15,625 | |
Apr 22 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | M | 19.65 | 100,000 | 1,965,000 | 50,000 | |
Apr 22 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Sell | S | 50.02 | 54,019 | 2,701,906 | 6,027 | 60 K to 6 K (-89.96 %) |
Apr 22 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Buy | M | 19.98 | 19,644 | 392,487 | 60,046 | 40.4 K to 60 K (+48.62 %) |
Apr 22 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Buy | M | 19.65 | 34,375 | 675,469 | 40,402 | 6 K to 40.4 K (+570.35 %) |
Apr 22 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Sell | S | 50.15 | 100,000 | 5,015,450 | 6,027 | 106 K to 6 K (-94.32 %) |
Apr 22 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Buy | M | 19.65 | 100,000 | 1,965,000 | 106,027 | 6 K to 106 K (+1,659.20 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 34.47 | 42,473 | 1,463,896 | 38,433,977 | 38.4 M to 38.4 M (+0.11 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 34.47 | 3,837 | 132,248 | 3,470,609 | 3.5 M to 3.5 M (+0.11 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 33.63 | 33,464 | 1,125,465 | 38,391,504 | 38.4 M to 38.4 M (+0.09 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 33.63 | 3,023 | 101,670 | 3,466,772 | 3.5 M to 3.5 M (+0.09 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 32.85 | 2,201 | 72,302 | 38,358,040 | 38.4 M to 38.4 M (+0.01 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 32.85 | 199 | 6,537 | 3,463,749 | 3.5 M to 3.5 M (+0.01 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 32.61 | 46,225 | 1,507,268 | 38,355,839 | 38.3 M to 38.4 M (+0.12 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 32.61 | 4,175 | 136,135 | 3,463,550 | 3.5 M to 3.5 M (+0.12 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.94 | 275 | 8,782 | 38,309,614 | 38.3 M to 38.3 M (0.00 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.94 | 25 | 798 | 3,459,375 | 3.5 M to 3.5 M (0.00 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 33.86 | 93,006 | 3,149,406 | 38,309,339 | 38.2 M to 38.3 M (+0.24 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 33.86 | 8,402 | 284,512 | 3,459,350 | 3.5 M to 3.5 M (+0.24 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 32.32 | 24,223 | 782,873 | 38,216,333 | 38.2 M to 38.2 M (+0.06 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 32.32 | 2,188 | 70,715 | 3,450,948 | 3.4 M to 3.5 M (+0.06 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 32.19 | 29,624 | 953,620 | 38,192,110 | 38.2 M to 38.2 M (+0.08 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 32.19 | 2,676 | 86,143 | 3,448,760 | 3.4 M to 3.4 M (+0.08 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.83 | 7,612 | 242,290 | 38,162,486 | 38.2 M to 38.2 M (+0.02 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.83 | 688 | 21,899 | 3,446,084 | 3.4 M to 3.4 M (+0.02 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.74 | 43,212 | 1,371,359 | 38,154,874 | 38.1 M to 38.2 M (+0.11 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.74 | 3,903 | 123,864 | 3,445,396 | 3.4 M to 3.4 M (+0.11 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.00 | 3,913 | 121,285 | 38,111,662 | 38.1 M to 38.1 M (+0.01 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.00 | 353 | 10,941 | 3,441,493 | 3.4 M to 3.4 M (+0.01 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.51 | 631,281 | 19,893,937 | 38,107,749 | 37.5 M to 38.1 M (+1.68 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.51 | 57,022 | 1,796,968 | 3,441,140 | 3.4 M to 3.4 M (+1.68 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.19 | 5,503 | 171,613 | 37,476,468 | 37.5 M to 37.5 M (+0.01 %) |
Mar 18 2020 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 31.19 | 497 | 15,499 | 3,384,118 | 3.4 M to 3.4 M (+0.01 %) |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Option Exercise | A | 0.00 | 10,889 | 0 | 10,889 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Option Exercise | A | 42.81 | 39,516 | 1,691,680 | 39,516 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | A | 0.00 | 10,889 | 0 | 10,889 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | A | 42.81 | 39,516 | 1,691,680 | 39,516 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | KIM AUSTIN D. | EVP & General Couns ... | Option Exercise | A | 0.00 | 6,533 | 0 | 6,533 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | KIM AUSTIN D. | EVP & General Couns ... | Option Exercise | A | 42.81 | 23,709 | 1,014,982 | 23,709 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | A | 0.00 | 21,777 | 0 | 21,777 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | A | 42.81 | 79,031 | 3,383,317 | 79,031 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | A | 0.00 | 38,110 | 0 | 38,110 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | A | 42.81 | 138,304 | 5,920,794 | 138,304 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Director | Option Exercise | M | 1.75 | 10,000 | 17,500 | 0 | |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Director | Sell | S | 42.19 | 10,000 | 421,900 | 0 | 10 K to 0 (-100.00 %) |
Jan 08 2020 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Director | Buy | M | 1.75 | 10,000 | 17,500 | 10,000 | 0 to 10 K |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Option Exercise | M | 35.86 | 72,979 | 2,617,027 | 312,500 | |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Option Exercise | M | 21.28 | 10,000 | 212,800 | 30,000 | |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Option Exercise | M | 19.98 | 22,500 | 449,550 | 577,500 | |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Sell | S | 43.74 | 5,032 | 220,075 | 2,499 | 7.5 K to 2.5 K (-66.82 %) |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Sell | S | 44.49 | 100,447 | 4,469,188 | 7,531 | 108 K to 7.5 K (-93.03 %) |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Buy | M | 35.86 | 72,979 | 2,617,027 | 107,978 | 35 K to 108 K (+208.52 %) |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Buy | M | 21.28 | 10,000 | 212,800 | 34,999 | 25 K to 35 K (+40.00 %) |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Buy | M | 19.98 | 22,500 | 449,550 | 24,999 | 2.5 K to 25 K (+900.36 %) |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | KIM AUSTIN D. | EVP & General Couns ... | Option Exercise | M | 17.58 | 17,500 | 307,650 | 122,500 | |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | KIM AUSTIN D. | EVP & General Couns ... | Sell | S | 45.06 | 17,500 | 788,576 | 509 | 18 K to 509 (-97.17 %) |
Dec 13 2019 | ACAD | ACADIA PHARMACEUTI ... | KIM AUSTIN D. | EVP & General Couns ... | Buy | M | 17.58 | 17,500 | 307,650 | 18,009 | 509 to 18 K (+3,438.11 %) |
Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Option Exercise | M | 35.86 | 14,521 | 520,723 | 385,479 | |
Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Sell | S | 50.05 | 3,502 | 175,286 | 1,623 | 5.1 K to 1.6 K (-68.33 %) |
Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Sell | S | 50.60 | 11,019 | 557,506 | 5,125 | 16.1 K to 5.1 K (-68.25 %) |
Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Buy | M | 35.86 | 14,521 | 520,723 | 16,144 | 1.6 K to 16.1 K (+894.70 %) |
Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | M | 15.81 | 36,000 | 569,160 | 64,000 | |
Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 49.09 | 19,478 | 956,253 | 0 | 19.5 K to 0 (-100.00 %) |
Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 49.81 | 5,502 | 274,044 | 19,478 | 25 K to 19.5 K (-22.03 %) |
Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Sell | S | 50.60 | 11,020 | 557,557 | 24,980 | 36 K to 25 K (-30.61 %) |
Dec 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Buy | M | 15.81 | 36,000 | 569,160 | 36,000 | 0 to 36 K |
Dec 06 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | M | 19.65 | 150,000 | 2,947,500 | 300,000 | |
Dec 06 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Sell | S | 51.32 | 28,256 | 1,450,098 | 2,954 | 31.2 K to 3 K (-90.54 %) |
Dec 06 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Sell | S | 52.09 | 40,159 | 2,091,882 | 31,210 | 71.4 K to 31.2 K (-56.27 %) |
Dec 06 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Sell | S | 52.82 | 81,585 | 4,309,320 | 71,369 | 153 K to 71.4 K (-53.34 %) |
Dec 06 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Buy | M | 19.65 | 150,000 | 2,947,500 | 152,954 | 3 K to 153 K (+5,077.86 %) |
Nov 21 2019 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | M | 0.00 | 6,250 | 0 | 18,750 | |
Nov 21 2019 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Sell | S | 46.41 | 2,160 | 100,246 | 6,027 | 8.2 K to 6 K (-26.38 %) |
Nov 21 2019 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Buy | M | 0.00 | 6,250 | 0 | 8,187 | 1.9 K to 8.2 K (+322.66 %) |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Option Exercise | M | 0.00 | 417 | 0 | 1,254 | |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Sell | S | 39.65 | 147 | 5,829 | 270 | 417 to 270 (-35.25 %) |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Buy | M | 0.00 | 417 | 0 | 417 | 0 to 417 |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Sell | S | 39.65 | 877 | 34,773 | 1,623 | 2.5 K to 1.6 K (-35.08 %) |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Buy | M | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | M | 0.00 | 2,968 | 0 | 8,907 | |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Sell | S | 39.65 | 1,031 | 40,879 | 1,937 | 3 K to 1.9 K (-34.74 %) |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Buy | M | 0.00 | 2,968 | 0 | 2,968 | 0 to 3 K |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | M | 0.00 | 5,937 | 0 | 17,813 | |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Sell | S | 39.65 | 2,983 | 118,276 | 2,954 | 5.9 K to 3 K (-50.24 %) |
Oct 17 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Buy | M | 0.00 | 5,937 | 0 | 5,937 | 0 to 5.9 K |
Oct 11 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | M | 19.65 | 120,208 | 2,362,087 | 450,000 | |
Oct 11 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Option Exercise | M | 19.65 | 29,792 | 585,413 | 570,208 | |
Oct 11 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Sell | S | 40.19 | 120,208 | 4,831,039 | 0 | 120.2 K to 0 (-100.00 %) |
Oct 11 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Buy | M | 19.65 | 120,208 | 2,362,087 | 120,208 | 0 to 120.2 K |
Oct 11 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Sell | S | 40.00 | 29,792 | 1,191,710 | 0 | 29.8 K to 0 (-100.00 %) |
Oct 11 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | CEO | Buy | M | 19.65 | 29,792 | 585,413 | 29,792 | 0 to 29.8 K |
Sep 20 2019 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 40.00 | 1,494,025 | 59,761,000 | 37,470,965 | 36 M to 37.5 M (+4.15 %) |
Sep 20 2019 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 40.00 | 68,475 | 2,739,000 | 3,383,621 | 3.3 M to 3.4 M (+2.07 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Option Exercise | M | 16.50 | 1,972 | 32,538 | 3,598 | |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Option Exercise | M | 35.80 | 4,593 | 164,429 | 4,594 | |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Option Exercise | M | 36.54 | 4,439 | 162,201 | 2,911 | |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Option Exercise | M | 29.24 | 6,063 | 177,282 | 552 | |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Option Exercise | M | 32.28 | 3,900 | 125,892 | 0 | |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Option Exercise | M | 20.65 | 7,500 | 154,875 | 0 | |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Sell | S | 41.18 | 4,645 | 191,281 | 0 | 4.6 K to 0 (-100.00 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Sell | S | 39.49 | 28,467 | 1,124,162 | 4,645 | 33.1 K to 4.6 K (-85.97 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Buy | M | 16.50 | 1,972 | 32,538 | 33,112 | 31.1 K to 33.1 K (+6.33 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Buy | M | 35.80 | 4,593 | 164,429 | 31,140 | 26.5 K to 31.1 K (+17.30 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Buy | M | 36.54 | 4,439 | 162,201 | 26,547 | 22.1 K to 26.5 K (+20.08 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Buy | M | 29.24 | 6,063 | 177,282 | 22,108 | 16 K to 22.1 K (+37.79 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Buy | M | 32.28 | 3,900 | 125,892 | 16,045 | 12.1 K to 16 K (+32.11 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Buy | M | 20.65 | 7,500 | 154,875 | 12,145 | 4.6 K to 12.1 K (+161.46 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Daly James M | Director | Option Exercise | M | 17.52 | 30,000 | 525,600 | 0 | |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Daly James M | Director | Sell | S | 38.39 | 400 | 15,356 | 0 | 400 to 0 (-100.00 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Daly James M | Director | Sell | S | 37.79 | 29,600 | 1,118,504 | 400 | 30 K to 400 (-98.67 %) |
Sep 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Daly James M | Director | Buy | M | 17.52 | 30,000 | 525,600 | 30,000 | 0 to 30 K |
Jun 28 2019 | ACAD | ACADIA PHARMACEUTI ... | SOLAND DANIEL B | Director | Option Exercise | A | 25.24 | 22,500 | 567,900 | 22,500 | |
Jun 28 2019 | ACAD | ACADIA PHARMACEUTI ... | Daly James M | Director | Option Exercise | A | 25.24 | 22,500 | 567,900 | 22,500 | |
Jun 28 2019 | ACAD | ACADIA PHARMACEUTI ... | HARRIGAN EDMUND | Director | Option Exercise | A | 25.24 | 22,500 | 567,900 | 22,500 | |
Jun 28 2019 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Director | Option Exercise | A | 25.24 | 15,000 | 378,600 | 15,000 | |
Jun 28 2019 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 25.24 | 30,000 | 757,200 | 30,000 | |
Jun 07 2019 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 31,229 | 0 | 102,876 | 71.6 K to 102.9 K (+43.59 %) |
Jun 07 2019 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 31,229 | 0 | 102,876 | 71.6 K to 102.9 K (+43.59 %) |
Jun 07 2019 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 421,756 | 0 | 3,315,146 | 3.7 M to 3.3 M (-11.29 %) |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Option Exercise | A | 0.00 | 3,442 | 0 | 3,442 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | Miller Eric Alejandro | Controller & PAO | Option Exercise | A | 25.12 | 6,039 | 151,700 | 6,039 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Option Exercise | A | 0.00 | 16,827 | 0 | 16,827 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | YANG MICHAEL J. | EVP and CCO | Option Exercise | A | 25.12 | 59,042 | 1,483,135 | 59,042 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | A | 0.00 | 12,981 | 0 | 12,981 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | Ridloff Elena | EVP and CFO | Option Exercise | A | 25.12 | 45,547 | 1,144,141 | 45,547 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | KIM AUSTIN D. | EVP & General Couns ... | Option Exercise | A | 0.00 | 12,019 | 0 | 12,019 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | KIM AUSTIN D. | EVP & General Couns ... | Option Exercise | A | 25.12 | 42,173 | 1,059,386 | 42,173 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | A | 0.00 | 38,462 | 0 | 38,462 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | A | 25.12 | 134,953 | 3,390,019 | 134,953 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | President and CEO | Option Exercise | A | 0.00 | 62,500 | 0 | 62,500 | |
May 01 2019 | ACAD | ACADIA PHARMACEUTI ... | DAVIS STEPHEN | President and CEO | Option Exercise | A | 25.12 | 219,298 | 5,508,766 | 219,298 | |
Jan 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Director | Option Exercise | M | 2.16 | 10,000 | 21,600 | 0 | |
Jan 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Director | Sell | S | 20.00 | 10,000 | 200,041 | 0 | 10 K to 0 (-100.00 %) |
Jan 11 2019 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Director | Buy | M | 2.16 | 10,000 | 21,600 | 10,000 | 0 to 10 K |
Dec 04 2018 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | J | 0.01 | 1,569 | 16 | 1,569 | |
Dec 04 2018 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | J | 0.01 | 1,569 | 16 | 1,569 | |
Dec 04 2018 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | J | 0.01 | 10,731 | 107 | 0 | |
Dec 04 2018 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 71,647 | 0 | 71,647 | 0 to 71.6 K |
Dec 04 2018 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 71,647 | 0 | 71,647 | 0 to 71.6 K |
Dec 04 2018 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 489,977 | 0 | 0 | 490 K to 0 (-100.00 %) |
Dec 04 2018 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 17.00 | 11,178,823 | 190,039,991 | 35,976,940 | 24.8 M to 36 M (+45.08 %) |
Dec 04 2018 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 17.00 | 585,882 | 9,959,994 | 3,736,902 | 3.2 M to 3.7 M (+18.59 %) |
Nov 20 2018 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 20 2018 | ACAD | ACADIA PHARMACEUTI ... | Stankovic Srdjan R. | President | Option Exercise | A | 18.12 | 150,000 | 2,718,000 | 150,000 |